Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).
Casili G, Scuderi SA, Lanza M, Filippone A, Mannino D, Giuffrida R, Colarossi C, Mare M, Capra AP, De Gaetano F, Portelli M, Militi A, Cuzzocrea S, Paterniti I, Esposito E.
Casili G, et al. Among authors: mare m.
Cancers (Basel). 2023 May 17;15(10):2796. doi: 10.3390/cancers15102796.
Cancers (Basel). 2023.
PMID: 37345134
Free PMC article.